Ausgabe 1/1998
Inhalt (11 Artikel)
The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index
K. Collett, R. Skjærven, B.O. Mæhle
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response
A. Makris, T.J. Powles, D.C. Allred, S. Ashley, M.G. Ormerod, J.C. Titley, M. Dowsett
A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases
Hitoshi Tsuda, Chinami Sakamaki, Shoichiro Tsugane, Takashi Fukutomi, Setsuo Hirohashi
Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue
Xiaoqi Yang, Lindon H. Young, Jeffrey M. Voigt
Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat
S. Sinha, J. Kaseta, S.J. Santner, L.M. Demers, W.J. Bremmer, R.J. Santen
Multidisciplinary weight management in locoregional breast cancer: results of a phase II study
Pamela Goodwin, Mary Jane Esplen, Kate Butler, Janis Winocur, Kathleen Pritchard, Sandy Brazel, Joe Gao, Andrea Miller
An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program.
Julia A. Knight, Alyssa R. Libstug, Veronika Moravan, Norman F. Boyd
Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice
Ilana Kogan, James R. Ballinger, Russell Redshaw, Eleftherios P. Diamandis, Dimitrios N. Melegos, Robert M. Kuba, A. Michael Rauth
Variation in endometrial thickening in women with amenorrhea on tamoxifen
J. Chang, T.J. Powles, S.E. Ashley, T. Iveson, R.K. Gregory, M. Dowsett
Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer
Els M.J.J. Berns, Iris L. van Staveren, Jan G.M. Klijn, John A. Foekens
Effect of menstrual phase on cell proliferative rate of breast cancer
Rosella Silvestrini, Antonella Luisi, Maria Grazia Daidone, Maria Gaetana Di Mauro